☰

Thomas B. Sundberg, Ph.D. - Publications

Affiliations: 
2009 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancer
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Arnett A, Moo KG, Flynn KJ, Sundberg TB, Johannessen L, Shamji AF, Gray NS, Decker T, Zheng Y, Gersuk VH, Rahman ZS, Levy DE, Marié IJ, Linsley PS, Xavier RJ, et al. The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4 T cells via a novel CDK8-GATA3-FOXP3 pathway. Molecular and Cellular Biology. MCB0008521. PMID 34124936 DOI: 10.1128/MCB.00085-21  0.391
2015 Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K, Aldrich LN, Sundberg TB, Paterson AM, Mordecai S, Dombkowski D, Schirmer M, Tan PH, Bhan AK, Roychoudhuri R, et al. The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. Elife. 4. PMID 25998054 DOI: 10.7554/Elife.05920  0.361
2011 Gatza E, Wahl DR, Opipari AW, Sundberg TB, Reddy P, Liu C, Glick GD, Ferrara JL. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Science Translational Medicine. 3: 67ra8. PMID 21270339 DOI: 10.1126/Scitranslmed.3001975  0.712
2011 Wahl D, Gatza E, Opipari A, Sundberg T, Reddy P, Liu C, Glick G, Ferrara J. Manipulation of the Bioenergetics of Alloreactive T Cells Leads to Their Selective Apoptosis and Arrests Graft Versus Host Disease Biology of Blood and Marrow Transplantation. 17: S149. DOI: 10.1016/J.Bbmt.2010.12.003  0.676
2009 Sundberg TB, Swenson L, Wahl DR, Opipari AW, Glick GD. Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes. The Journal of Pharmacology and Experimental Therapeutics. 331: 437-44. PMID 19706792 DOI: 10.1124/Jpet.109.156422  0.69
2008 Bhagavathula N, Nerusu KC, Hanosh A, Aslam MN, Sundberg TB, Opipari AW, Johnson K, Kang S, Glick GD, Varani J. 7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodeficient mouse transplant model. The Journal of Pharmacology and Experimental Therapeutics. 324: 938-47. PMID 18055879 DOI: 10.1124/Jpet.107.130955  0.576
2006 Francis TM, Sundberg TB, Cleary J, Groendyke T, Opipari AW, Glick GD. Identification of cytotoxic, T-cell-selective 1,4-benzodiazepine-2,5-diones. Bioorganic & Medicinal Chemistry Letters. 16: 2423-7. PMID 16488147 DOI: 10.1016/J.Bmcl.2006.01.113  0.629
2006 Sundberg TB, Ney GM, Subramanian C, Opipari AW, Glick GD. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation. Cancer Research. 66: 1775-82. PMID 16452238 DOI: 10.1158/0008-5472.Can-05-3476  0.615
Show low-probability matches.